Insider · CIK 0002064940
Sarbani Chaudhuri
Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing May 11, 2026, latest Aug 13, 2026.
In brief
Sarbani Chaudhuri files SEC Form 4 as officer at RCKT (ROCKET PHARMACEUTICALS, INC.). Since May 11, 2026, Sarbani Chaudhuri has reported 0 open-market buys worth $0 and 2 open-market sells worth $84k, the latest filed on Aug 13, 2026.
A track record needs three past buys with six months of prices behind them; Sarbani Chaudhuri has 0, so none is measured yet.
The newest scored trade: sold $16k of RCKT on Aug 11, 2026, filed Aug 13, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $84k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RCKT: ROCKET PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $16k 4,701 shares | -2% | +35% from low-34% from high | |
| 38Weak | ROCKET PHARMACEUTICALS, INC. | $68k 17,650 shares | -6% | +58% from low-48% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 4,701 0.00% of outstanding | $16k | Aug 11, 2026 | none |
| May 7, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 17,650 0.02% of outstanding | $68k | May 7, 2026 | none |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -4,701 | $3.50 | $16k | 262,809 | Aug 13, 2026 |
| May 7, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -17,650 | $3.84 | $68k | 267,510 | May 11, 2026 |
| Feb 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +125,924 | $0.00 | $0 | 285,160 | Feb 13, 2026 |
| Feb 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +189,076 | $0.00 | $0 | 189,076 | Feb 13, 2026 |
Questions about Sarbani Chaudhuri
Answered from the filings on this page, as of the latest one.
Is Sarbani Chaudhuri buying or selling?
In the last 12 months Sarbani Chaudhuri reported 0 open-market buys worth $0 and 2 open-market sells worth $84k on SEC Form 4; the latest was sold $16k of RCKT on Aug 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Sarbani Chaudhuri's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sarbani Chaudhuri has 0.
Where does Sarbani Chaudhuri file Form 4?
Sarbani Chaudhuri has filed Form 4 at RCKT (ROCKET PHARMACEUTICALS, INC.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.